Scholars Central

Conference abstractPublished 7 Jun 2017

A new class of b-lactam antibiotics active against drug-sensitive and drug-resistant Mycobacterium tuberculosis

Authors: Monika I Konaklieva

American University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

We have designed, synthesized, and tested monocyclic β-lactams that carry aryl-thioether group at C4. These lactams have shown good intrinsic activity against serine β-lactamase producing Mycobacterium tuberculosis H37Rv (Mtb). Some of the compounds have demonstrated minimal inhibitory concentration (MIC) as low as 6.25 μg/ml in 7H9 and 0.19 μg/ml in GAST. Our investigations indicate that these compounds are cidal to both replicating and non-replicating persistent Mtb. These compounds have also shown activity against multi-drug resistant strains of M. tuberculosis. Therefore, they are promising candidates for lead discovery. Mechanism of action and target identification studies are currently underway.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectInfectious Diseases
  • SubjectMicrobiology
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Monika I Konaklieva”